Karen Reeves - 14 Feb 2022 Form 3 Insider Report for Kiromic Biopharma, Inc. (KRBPQ)

Role: Director
Signature: /s/ Daniel Clark, attorney-in-fact
Issuer symbol: KRBPQ
Transactions as of: 14 Feb 2022
Net transactions value: $0
Form type: 3
Filing time: 24 May 2022, 06:00:39 UTC
Next filing: 05 Jul 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney